Gary Charles Robb is Chief Business Officer of CORCEPT THERAPEUTICS INC. Currently has a direct ownership of 23,156 shares of CORT, which is worth approximately $1.25 Million. The most recent transaction as insider was on Aug 30, 2022, when has been sold 167,323 shares (Common Stock) at a price of $2.08 per share, resulting in proceeds of $348,032. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.2K
1.69% 3M change
12.19% 12M change
Total Value Held $1.25 Million

Gary Charles Robb Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 30 2022
BUY
Exercise of conversion of derivative security
$348,032 $2.08 p/Share
167,323 Added 46.64%
191,446 Common Stock
Jul 06 2022
SELL
Open market or private sale
$1,170,000 $26.0 p/Share
45,000 Reduced 65.1%
24,123 Common Stock
Jul 06 2022
BUY
Exercise of conversion of derivative security
$67,968 $2.08 p/Share
32,677 Added 32.1%
69,123 Common Stock
May 19 2022
SELL
Open market or private sale
$119,905 $19.57 p/Share
6,127 Reduced 14.39%
36,446 Common Stock
May 18 2022
SELL
Open market or private sale
$2,502 $19.55 p/Share
128 Reduced 0.3%
42,573 Common Stock
May 17 2022
SELL
Open market or private sale
$561,965 $19.55 p/Share
28,745 Reduced 40.23%
42,701 Common Stock
Mar 18 2022
SELL
Open market or private sale
$123,054 $24.67 p/Share
4,988 Reduced 6.53%
71,446 Common Stock
Mar 17 2022
SELL
Open market or private sale
$185,396 $24.68 p/Share
7,512 Reduced 8.95%
76,434 Common Stock
Sep 15 2021
SELL
Open market or private sale
$980,508 $20.49 p/Share
47,853 Reduced 35.26%
87,848 Common Stock
Sep 14 2021
SELL
Open market or private sale
$16,733 $20.76 p/Share
806 Reduced 0.59%
135,701 Common Stock
Sep 13 2021
SELL
Open market or private sale
$132,463 $20.89 p/Share
6,341 Reduced 4.44%
136,507 Common Stock
Aug 30 2021
SELL
Payment of exercise price or tax liability
$1,742,595 $21.53 p/Share
80,938 Reduced 36.17%
142,848 Common Stock
Aug 30 2021
BUY
Exercise of conversion of derivative security
$400,000 $2.7 p/Share
148,148 Added 39.83%
223,786 Common Stock
Apr 23 2021
SELL
Open market or private sale
$240,200 $24.02 p/Share
10,000 Reduced 11.68%
75,638 Common Stock
Feb 12 2021
SELL
Open market or private sale
$3,163,462 $28.22 p/Share
112,100 Reduced 56.69%
85,638 Common Stock
Feb 11 2021
SELL
Open market or private sale
$101,252 $29.78 p/Share
3,400 Reduced 1.69%
197,738 Common Stock
Jan 22 2021
SELL
Payment of exercise price or tax liability
$7,260,216 $28.06 p/Share
258,739 Reduced 56.26%
201,138 Common Stock
Jan 22 2021
BUY
Exercise of conversion of derivative security
$1,220,000 $2.7 p/Share
451,852 Added 49.56%
459,877 Common Stock
GCR

Gary Charles Robb

Chief Business Officer
Menlo Park, CA

Track Institutional and Insider Activities on CORT

Follow CORCEPT THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CORT shares.

Notify only if

Insider Trading

Get notified when an Corcept Therapeutics Inc insider buys or sells CORT shares.

Notify only if

News

Receive news related to CORCEPT THERAPEUTICS INC

Track Activities on CORT